Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for RVTY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 191.94M
March 31, 2026 115.23M
December 31, 2025 181.96M
September 30, 2025 138.50M
June 30, 2025 134.25M
March 31, 2025 125.75M
December 31, 2024 174.23M
September 30, 2024 147.88M
June 30, 2024 158.62M
March 31, 2024 147.56M
December 31, 2023 196.61M
September 30, 2023 -33.48M
June 30, 2023 -135.32M
March 31, 2023 63.46M
December 31, 2022 139.16M
September 30, 2022 117.30M
June 30, 2022 140.14M
March 31, 2022 283.22M
December 31, 2021 335.59M
September 30, 2021 313.80M
June 30, 2021 287.86M
March 31, 2021 473.50M
December 31, 2020 482.10M
September 30, 2020 211.43M
June 30, 2020 138.60M
Date Value
March 31, 2020 60.05M
December 31, 2019 215.21M
September 30, 2019 106.72M
June 30, 2019 46.86M
March 31, 2019 -5.316M
December 31, 2018 159.42M
September 30, 2018 93.19M
June 30, 2018 72.98M
March 31, 2018 -14.56M
December 31, 2017 128.10M
September 30, 2017 58.50M
June 30, 2017 48.12M
March 31, 2017 53.74M
December 31, 2016 148.72M
September 30, 2016 73.61M
June 30, 2016 96.24M
March 31, 2016 32.04M
December 31, 2015 125.24M
September 30, 2015 60.72M
June 30, 2015 63.47M
March 31, 2015 37.66M
December 31, 2014 96.56M
September 30, 2014 62.93M
June 30, 2014 54.40M
March 31, 2014 67.71M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 519.00M
Danaher Corp. 1.534B
Thermo Fisher Scientific, Inc. 2.125B
Waters Corp. 201.00M
Bio-Rad Laboratories, Inc. 98.70M